- Home
- SRM vs HOTH Comparison
SRM vs HOTH Comparison
Compare SRM & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- HOTH
- Stock Information
- Founded
- SRM 1979
- HOTH 2017
- Country
- SRM United States
- HOTH United States
- Employees
- SRM N/A
- HOTH N/A
- Industry
- SRM
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- HOTH Health Care
- Exchange
- SRM Nasdaq
- HOTH Nasdaq
- Market Cap
- SRM 9.0M
- HOTH 8.3M
- IPO Year
- SRM 2023
- HOTH 2019
- Fundamental
- Price
- SRM $0.43
- HOTH $0.85
- Analyst Decision
- SRM
- HOTH Strong Buy
- Analyst Count
- SRM 0
- HOTH 3
- Target Price
- SRM N/A
- HOTH $4.00
- AVG Volume (30 Days)
- SRM 575.8K
- HOTH 212.0K
- Earning Date
- SRM 05-09-2025
- HOTH 05-12-2025
- Dividend Yield
- SRM N/A
- HOTH N/A
- EPS Growth
- SRM N/A
- HOTH N/A
- EPS
- SRM N/A
- HOTH N/A
- Revenue
- SRM $4,394,659.00
- HOTH N/A
- Revenue This Year
- SRM N/A
- HOTH N/A
- Revenue Next Year
- SRM N/A
- HOTH N/A
- P/E Ratio
- SRM N/A
- HOTH N/A
- Revenue Growth
- SRM N/A
- HOTH N/A
- 52 Week Low
- SRM $0.26
- HOTH $0.58
- 52 Week High
- SRM $1.66
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SRM 54.35
- HOTH 44.29
- Support Level
- SRM $0.40
- HOTH $0.87
- Resistance Level
- SRM $0.45
- HOTH $0.98
- Average True Range (ATR)
- SRM 0.04
- HOTH 0.06
- MACD
- SRM 0.00
- HOTH 0.00
- Stochastic Oscillator
- SRM 70.71
- HOTH 15.03
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.